HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update
Clinical Infectious Diseases · 06.10.2025 · 81 (3) · 539-542
DOI: 10.1093/cid/ciaf110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 12.03.2025. Verfasst von Charlotte Charpentier und 13 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM, UMR 1137, IAME, Paris, France. Hauptthemen laut MEDLINE: HIV-2, Drug Resistance, Viral, HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, INSERM, UMR 1137, IAME, Paris, France.
- Service de Virologie, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.
- Praxis for Infectiology, Hamburg, Germany.
- Deutsche Arbeitsgemeinschaft niedergelassener Ärzte in der Versorgung HIV-Infizierter (dagnä), Berlin, Germany.
- Faculty of Medicine and University Hospital of Cologne, Institute of Virology, University of Cologne, Cologne, Germany.
- Deutsche AIDS-Gesellschaft e.V. (DAIG), Essen, Germany.
ORCID-Profile: Dirk Berzow, Quentin Le Hingrat, Rolf Kaiser, Perpetua Gomes, Jade Ghosn, Jeroen J A van Kampen, Björn-Erik Ole Jensen, Michael Böhm, Martin Obermeier
Zitieren
APA
Charpentier, C., Berzow, D., Le Hingrat, Q., Kaiser, R., Gomes, P., Miranda, A. C., Damond, F., Ghosn, J., van Kampen, J. J. A., Jensen, B. O., Böhm, M., Wensing, A. M. J., Descamps, D., & Obermeier, M. (2025). HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update. Clinical Infectious Diseases, 81(3), 539-542. https://doi.org/10.1093/cid/ciaf110
Vancouver
Charpentier C, Berzow D, Le Hingrat Q, Kaiser R, Gomes P, Miranda AC, et al. HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update. Clinical Infectious Diseases. 2025;81(3):539-542. doi:10.1093/cid/ciaf110
BibTeX
@article{Charpentier2025,
author = {Charpentier, Charlotte and Berzow, Dirk and Le Hingrat, Quentin and Kaiser, Rolf and Gomes, Perpetua and Miranda, Ana Claudia and Damond, Florence and Ghosn, Jade and van Kampen, Jeroen J A and Jensen, Björn-Erik Ole and Böhm, Michael and Wensing, Annemarie M J and Descamps, Diane and Obermeier, Martin},
title = {HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {81},
number = {3},
pages = {539--542},
doi = {10.1093/cid/ciaf110}
}
EUVIMED